| Literature DB >> 27709413 |
Seung-Chul Choi1, Anton A Titov1, Ramya Sivakumar1, Wei Li1,2, Laurence Morel3.
Abstract
Cellular metabolism represents a newly identified checkpoint of effector functions in the immune system. A solid body of work has characterized the metabolic requirements of normal T cells during activation and differentiation into polarized effector subsets. Similar studies have been initiated to characterize the metabolic requirements for B cells and myeloid cells. Only a few studies though have characterized the metabolism of immune cells in the context of autoimmune diseases. Here, we review what is known on the altered metabolic patterns of CD4+ T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis. We also discuss how defects in immune metabolism in lupus can be targeted therapeutically.Entities:
Keywords: Autoimmunity; B cells; Immunometabolism; Lupus; Myeloid cells; T cells; Therapeutic targets
Mesh:
Year: 2016 PMID: 27709413 DOI: 10.1007/s11926-016-0615-7
Source DB: PubMed Journal: Curr Rheumatol Rep ISSN: 1523-3774 Impact factor: 4.592